Kynurenic acid has a dual action on AMPA receptor responses

被引:140
作者
Prescott, Christina
Weeks, Autumn M. [1 ]
Staley, Kevin J.
Partin, Kathryn M.
机构
[1] Colorado State Univ, Dept Biomed Sci, Div Neurosci, Ft Collins, CO 80523 USA
[2] Univ Colorado, Hlth Sci Ctr, Dept Neurol & Pediat, Denver, CO 80262 USA
关键词
glutamate receptor; allosteric modulation; desensitization; electrophysiology; pharmacology;
D O I
10.1016/j.neulet.2006.03.051
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Glutamate is the predominant excitatory neurotransmitter in the central nervous system. The receptors that bind glutamate, including N-methyl-D-aspartate (NMDA) and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor subtypes, are strongly implicated in higher cognitive processes, especially learning and memory. Loss of glutamate receptor function impairs the ability to acquire and retain information in some patients subsequent to stroke or brain injury, and positive allosteric modulators of glutamate receptors can restore learning and memory in some of these patients. Here we demonstrate that kynurenic acid (KYNA), an endogenous tryptophan metabolite, acts upon heterologous AMPA receptors via two distinct mechanisms. Low (nanomolar to micromolar) concentrations of KYNA facilitate AMPA receptor responses, whereas high (millimolar) concentrations of KYNA competitively antagonize glutamate receptors. Low concentrations of KYNA appear to increase current responses through allosteric modulation of desensitization of AMPA receptors. These findings suggest the possibility that low concentrations of endogenous KYNA acting at AMPA receptors may be a positive modulator of excitatory synaptic transmission. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:108 / 112
页数:5
相关论文
共 27 条
[1]   GYKI 52466 has positive modulatory effects on AMPA receptors [J].
Arai, AC .
BRAIN RESEARCH, 2001, 892 (02) :396-400
[2]   Synthesis, pharmacokinetics and anticonvulsant activity of 7-chlorokynurenic acid prodrugs [J].
Bonina, FP ;
Arenare, L ;
Ippolito, R ;
Boatto, G ;
Battaglia, G ;
Bruno, V ;
de Caprariis, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 202 (1-2) :79-88
[3]  
DOMENICI MR, 1996, LIFE SCI, V58, P391
[4]   Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia [J].
Erhardt, S ;
Blennow, K ;
Nordin, C ;
Skogh, E ;
Lindström, LH ;
Engberg, G .
NEUROSCIENCE LETTERS, 2001, 313 (1-2) :96-98
[5]   Molecular constituents of neuronal AMPA receptors [J].
Fukata, Y ;
Tzingounis, AV ;
Trinidad, JC ;
Fukata, M ;
Burlingame, AL ;
Nicoll, RA ;
Bredt, DS .
JOURNAL OF CELL BIOLOGY, 2005, 169 (03) :399-404
[6]   Electrochemical and in vitro evaluation of the redox-properties of kynurenine species [J].
Giles, GI ;
Collins, CA ;
Stone, TW ;
Jacob, C .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 300 (03) :719-724
[7]   Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection [J].
Guillemin, GJ ;
Kerr, SJ ;
Smythe, GA ;
Smith, DG ;
Kapoor, V ;
Armati, PJ ;
Croitoru, J ;
Brew, BJ .
JOURNAL OF NEUROCHEMISTRY, 2001, 78 (04) :842-853
[8]   The brain metabolite kynurenic acid inhibits α7 nicotinic receptor activity and increases non-α7 nicotinic receptor expression:: Physiopathological implications [J].
Hilmas, C ;
Pereira, EFR ;
Alkondon, M ;
Rassoulpour, A ;
Schwarcz, R ;
Albuquerque, EX .
JOURNAL OF NEUROSCIENCE, 2001, 21 (19) :7463-7473
[9]   Chronic treatment with ionotropic glutamate receptor antagonist kynurenate affects GABAergic synaptic transmission in rat hippocampal cell cultures [J].
Ivanova, SY ;
Storozhuk, MV ;
Melnick, IV ;
Kostyuk, PG .
NEUROSCIENCE LETTERS, 2003, 341 (01) :61-64
[10]   Structural basis for partial agonist action at ionotropic glutamate receptors [J].
Jin, RS ;
Banke, TG ;
Mayer, ML ;
Traynelis, SF ;
Gouaux, E .
NATURE NEUROSCIENCE, 2003, 6 (08) :803-810